- Home
- MUX vs ANAB Comparison
MUX vs ANAB Comparison
Compare MUX & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- ANAB
- Stock Information
- Founded
- MUX 1979
- ANAB 2005
- Country
- MUX Canada
- ANAB United States
- Employees
- MUX N/A
- ANAB N/A
- Industry
- MUX Precious Metals
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- ANAB Health Care
- Exchange
- MUX Nasdaq
- ANAB Nasdaq
- Market Cap
- MUX 579.8M
- ANAB 621.1M
- IPO Year
- MUX N/A
- ANAB 2017
- Fundamental
- Price
- MUX $10.18
- ANAB $20.14
- Analyst Decision
- MUX Strong Buy
- ANAB Buy
- Analyst Count
- MUX 2
- ANAB 10
- Target Price
- MUX $16.00
- ANAB $48.00
- AVG Volume (30 Days)
- MUX 896.7K
- ANAB 500.2K
- Earning Date
- MUX 08-06-2025
- ANAB 08-06-2025
- Dividend Yield
- MUX N/A
- ANAB N/A
- EPS Growth
- MUX N/A
- ANAB N/A
- EPS
- MUX N/A
- ANAB N/A
- Revenue
- MUX $168,169,000.00
- ANAB $123,164,000.00
- Revenue This Year
- MUX $1.09
- ANAB N/A
- Revenue Next Year
- MUX N/A
- ANAB $24.39
- P/E Ratio
- MUX N/A
- ANAB N/A
- Revenue Growth
- MUX N/A
- ANAB 304.17
- 52 Week Low
- MUX $6.38
- ANAB $12.21
- 52 Week High
- MUX $11.80
- ANAB $40.70
- Technical
- Relative Strength Index (RSI)
- MUX 44.12
- ANAB 31.39
- Support Level
- MUX $9.82
- ANAB $19.55
- Resistance Level
- MUX $10.85
- ANAB $22.03
- Average True Range (ATR)
- MUX 0.43
- ANAB 1.50
- MACD
- MUX -0.09
- ANAB -0.53
- Stochastic Oscillator
- MUX 26.53
- ANAB 12.05
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).